Skip to content
OpenCapital
Get started

ADMA Biologics ADMA EBITDA

EBITDA at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$50.68M+11.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$34.51M-26.0%
Zymeworks logo
ZymeworksZYME
-$45.98M-99.8%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$82.36M-31.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——
Quest Diagnostics logo
Quest DiagnosticsDGX
——

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Calculated from ADMA Biologics’s reported figures.

$58.3Mebit+
$1.8MDepreciation Depletion & Amortization
=$60.07M

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's EBITDA?
ADMA Biologics (ADMA) reported EBITDA of $60.07M in Q1 2026.
How has ADMA Biologics's EBITDA changed year-over-year?
ADMA Biologics's EBITDA increased by 63.3% year-over-year, from $36.78M to $60.07M.
What is the long-term trend for ADMA Biologics's EBITDA?
Over 4 years (2021 to 2025), ADMA Biologics's EBITDA has grown at a 39.3% compound annual growth rate (CAGR), from -$52.88M to $199.34M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.